NonClinical Safety Evaluation in Pharmaceutical Development-Michael Taylor, Ph.D., DABT-01/17/2012 - 8:30am

Event Information
Event Topic: 
NonClinical Safety Evaluation in Pharmaceutical Development
Event Date: 
01/17/2012 - 8:30am
Event Location: 
Sunnyvale City Council Chambers, 456 West Olive Ave., Sunnyale, CA
Speaker Information
Event Speaker: 
Michael Taylor, Ph.D., DABT
Event Speaker Company: 
Non-Clinical Safety Assessment
Event Speaker Bio: 

Michael Taylor, MD

Dr. Taylor is the owner of Non-Clinical Safety Assessment, a consulting firm focusing on the safety evaluation of drugs and medical devices. Dr Taylor has more than 20 years of pharmaceutical R&D experience industry and has held senior executive positions with several local companies including Alexza Pharmaceuticals, Protein Design Labs, DURECT Corporation, Roche Biosciences, and Syntex Research. He is certified by the American Board of Toxicology and holds Ph.D. and M.S. degrees in toxicology from Utah State University and postdoctoral training with the NIH and CNRS of France.

Event Details
Event Details: 

The presentation will provide an overview of the role of nonclinical safety evaluation in product development. Discussion will cover development of new molecules, repositioning of old drugs, and medical devices with focus on FDA expectations, timelines, and costs. The presentation will include discussion of early considerations (preclinical) as well as development/registration considerations.